Corient Private Wealth LLC Decreases Position in Aflac Incorporated (NYSE:AFL)

Corient Private Wealth LLC lessened its position in Aflac Incorporated (NYSE:AFL) by 1.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 631,367 shares of the financial services provider’s stock after selling 7,485 shares during the period. Corient Private Wealth LLC’s holdings in Aflac were worth $65,309,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Franklin Resources Inc. boosted its stake in Aflac by 75.2% during the 3rd quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock valued at $88,533,000 after purchasing an additional 333,083 shares during the last quarter. Transamerica Financial Advisors Inc. bought a new position in shares of Aflac during the third quarter valued at $979,000. Roxbury Financial LLC purchased a new stake in shares of Aflac during the fourth quarter valued at $948,000. FMR LLC increased its holdings in Aflac by 4.0% in the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after buying an additional 45,745 shares in the last quarter. Finally, Willis Investment Counsel raised its position in Aflac by 1.2% in the 4th quarter. Willis Investment Counsel now owns 273,466 shares of the financial services provider’s stock worth $28,287,000 after buying an additional 3,357 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Insider Activity at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now owns 49,962 shares in the company, valued at $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Morgan Stanley raised their price target on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. Keefe, Bruyette & Woods dropped their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a report on Wednesday, February 12th. Piper Sandler decreased their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Barclays dropped their price target on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Finally, StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $103.36.

Aflac Stock Up 2.2 %

AFL stock opened at $107.44 on Monday. The business’s 50-day moving average price is $105.37 and its 200-day moving average price is $107.68. The stock has a market cap of $58.72 billion, a P/E ratio of 11.19, a PEG ratio of 3.24 and a beta of 0.93. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.